Acetyl-H2BFS (K12) Antibody

What is Acetyl-H2BFS (K12) Antibody and what epitope does it specifically recognize?

Acetyl-H2BFS (K12) Antibody is a polyclonal antibody typically raised in rabbits that specifically recognizes histone H2B (H2BFS) when acetylated at the lysine 12 (K12) position . The antibody is generated using synthesized peptides derived from human Histone H2B around the acetylation site of K12 as immunogens . This specificity allows researchers to detect post-translational modifications that are crucial for epigenetic regulation.

The antibody targets H2BFS (Histone H2B Family Member S), which is a core component of nucleosomes. The acetylation at the K12 position represents a specific histone modification that plays significant roles in chromatin structure and function .

H2B K12 acetylation is a critical epigenetic mark with multiple regulatory functions:

• Chromatin structure modulation: As a core component of nucleosomes, acetylated H2B contributes to the loosening of chromatin structure, making DNA more accessible to transcription machinery .

• Transcriptional regulation: K12 acetylation is associated with active gene transcription by facilitating the binding of transcription factors and coactivators .

• DNA repair processes: H2B modifications, including K12 acetylation, play roles in DNA damage response pathways by modulating chromatin accessibility for repair proteins .

• Chromosomal stability: Proper histone modifications are essential for maintaining genomic integrity through various cell cycles .

• Telomere maintenance: H2BFS is involved in pathways related to the packaging of telomere ends, suggesting roles in telomere structure and function .

Which species reactivity is confirmed for Acetyl-H2BFS (K12) Antibody?

Based on experimental validation, Acetyl-H2BFS (K12) Antibody demonstrates reactivity with samples from the following species:

• Human (Homo sapiens)

• Mouse (Mus musculus)

• Monkey (particularly African green monkey)

This cross-species reactivity is valuable for comparative studies examining evolutionary conservation of histone acetylation patterns .

What are the optimal storage conditions and stability considerations for Acetyl-H2BFS (K12) Antibody?

For maximum stability and activity retention:

• Storage conditions: Store at -20°C for long-term preservation (up to 1 year)

• Buffer composition: Typically supplied in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide

• Aliquoting: Upon receipt, divide into small working aliquots to avoid repeated freeze-thaw cycles

• Handling: Always keep on ice when working with the antibody and avoid exposure to high temperatures

• Contamination prevention: Use sterile technique when handling to prevent microbial contamination

Proper storage significantly impacts antibody performance across all applications and extends shelf-life .

How can specificity of Acetyl-H2BFS (K12) Antibody be validated experimentally?

Multiple complementary approaches should be employed to verify antibody specificity:

• Peptide competition assay: Pre-incubate the antibody with excess acetylated peptide (the immunogen) before application. Signal elimination confirms specificity .

• Treatment with HDAC inhibitors: Compare samples treated with histone deacetylase inhibitors (e.g., TSA) against untreated controls. Enhanced signal in treated samples supports specificity for the acetylated form .

• Knockout/knockdown verification: Use samples from H2B knockout/knockdown models as negative controls.

• Molecular weight confirmation: In Western blot applications, verify the detected band corresponds to the expected molecular weight of H2B (approximately 14 kDa) .

• Cross-reactivity testing: Test against related histone modifications to ensure the antibody doesn't recognize other acetylation sites.

As demonstrated in published data, comparison of COS-7 cells treated with TSA (400nM, 24hours) with and without acetylated peptide competition shows signal elimination with the competing peptide, confirming specificity .

What controls should be included when using Acetyl-H2BFS (K12) Antibody in ChIP experiments?

Robust ChIP experiments with Acetyl-H2BFS (K12) Antibody require multiple controls:

• Input control: Retain a portion (typically 5-10%) of the pre-immunoprecipitated chromatin to normalize ChIP enrichment.

• IgG negative control: Perform parallel ChIP with non-specific IgG from the same species as the Acetyl-H2BFS (K12) Antibody.

• Positive control antibody: Include a well-characterized antibody against a different histone mark (e.g., H3K4me3) known to be present in your system.

• Positive control loci: Analyze regions known to be enriched for H2B K12 acetylation.

• Negative control loci: Examine heterochromatic regions typically depleted of active histone marks.

• Acetylation modulation: Where appropriate, include samples treated with HDAC inhibitors to increase global acetylation levels and confirm antibody responsiveness .

For ChIP-seq experiments specifically, additional controls monitoring library preparation and sequencing quality should be included .

What sample preparation methods enhance detection of H2B K12 acetylation?

Optimal detection of H2B K12 acetylation requires careful sample preparation:

• Histone extraction protocols:

  • For Western blotting: Acid extraction methods (using sulfuric acid or hydrochloric acid) effectively isolate histones while preserving modifications

  • For ChIP: Formaldehyde crosslinking (typically 1% for 10 minutes) followed by sonication to appropriate fragment sizes (200-500bp)

• HDAC inhibitor treatment:

  • Add HDAC inhibitors (e.g., sodium butyrate, TSA) to all buffers during extraction

  • Pre-treat cells/tissues with HDAC inhibitors to enhance acetylation signals

• Phosphatase inhibitors: Include phosphatase inhibitors in extraction buffers to prevent potential modification cross-talk

• Reducing agents: Limit exposure to strong reducing agents which may affect antibody binding

• Tissue fixation for IHC: For paraffin-embedded tissues, antigen retrieval methods (typically heat-induced in citrate buffer pH 6.0) significantly improve detection sensitivity

What are common issues in Western blot applications of Acetyl-H2BFS (K12) Antibody and their solutions?

Experimental validation shows a clear band at approximately 14 kDa in TSA-treated COS-7 cells that disappears with acetylated peptide competition, demonstrating specificity and appropriate troubleshooting approaches .

How can ChIP-seq data using Acetyl-H2BFS (K12) Antibody be properly analyzed?

Analysis of ChIP-seq data for H2B K12 acetylation requires specialized bioinformatic approaches:

• Quality control:

  • Assess sequencing quality (FASTQC)

  • Evaluate read depth (10-20 million uniquely mapped reads minimum)

  • Check fragment size distribution

• Peak calling optimization:

  • Use appropriate algorithms for histone modifications (MACS2 with broad peak settings)

  • Incorporate input controls for background normalization

  • Apply FDR cutoffs (typically q < 0.05)

• Signal distribution analysis:

  • Generate heatmaps of signal around transcription start sites

  • Create average profile plots for different genomic features

  • Compare with other active histone marks (H3K27ac, H3K4me3)

• Integration with gene expression data:

  • Correlate H2B K12ac peaks with RNA-seq datasets

  • Perform gene ontology analysis of marked genes

  • Evaluate co-occurrence with transcription factor binding sites

• Differential binding analysis:

  • Use DESeq2 or edgeR for comparing conditions

  • Apply appropriate normalization methods for ChIP-seq (RPKM, TMM)

  • Validate key differential regions by ChIP-qPCR

How should conflicting results between different detection methods be reconciled?

When facing discrepancies in H2B K12 acetylation detection across different methods:

• Characterize method-specific limitations:

  • Western blot: Limited spatial information but good for global levels

  • IHC/IF: Good spatial information but potential cross-reactivity

  • ChIP: High specificity for genomic locations but potential bias in chromatin accessibility

  • ChIP-seq: Genome-wide but affected by sequencing depth and data processing

• Methodological validation:

  • Confirm antibody performance in each application separately

  • Use complementary antibodies targeting the same modification

  • Apply peptide competition controls in each method

• Biological variability assessment:

  • Evaluate developmental stage and cell cycle effects

  • Consider dynamic nature of histone modifications

  • Assess potential antagonistic modifications at neighboring residues

• Technical standardization:

  • Standardize sample preparation across methods

  • Use the same positive and negative controls

  • Ensure consistent HDAC inhibitor treatments

• Orthogonal validation:

  • Employ mass spectrometry to quantify acetylation levels

  • Use genetic approaches (e.g., histone mutants, HAT/HDAC perturbations)

  • Consider targeted approaches like CUT&RUN or CUT&Tag for validation

How can Acetyl-H2BFS (K12) Antibody be used to investigate the relationship between histone acetylation and disease states?

Leveraging Acetyl-H2BFS (K12) Antibody for disease-related research requires sophisticated experimental designs:

• Cancer research applications:

  • Compare H2B K12 acetylation patterns between tumor and adjacent normal tissues using IHC

  • Correlate acetylation patterns with cancer progression and patient outcomes

  • Investigate relationship with endometrial stromal sarcoma, which has documented connections to H2BFS dysregulation

• Epigenetic dysregulation models:

  • Profile H2B K12 acetylation changes following treatment with epigenetic modulators

  • Perform ChIP-seq before and after HDAC inhibitor treatment in disease models

  • Correlate changes with transcriptional reprogramming events

• Mechanistic studies:

  • Investigate interactions between H2B K12 acetylation and telomere packaging pathways

  • Examine roles in antimicrobial barrier formation in colonic epithelium

  • Study potential contributions to bactericidal activity of amniotic fluid

• Biomarker development:

  • Assess H2B K12 acetylation as a potential prognostic or diagnostic marker

  • Develop quantitative assays using the antibody for clinical sample analysis

  • Correlate with other established epigenetic biomarkers

What approaches can reveal interactions between H2B K12 acetylation and other histone modifications?

Understanding histone modification crosstalk requires multifaceted experimental strategies:

• Sequential ChIP (Re-ChIP):

  • First immunoprecipitate with Acetyl-H2BFS (K12) Antibody

  • Re-immunoprecipitate with antibodies against other modifications

  • Analyze co-occurrence at specific genomic loci

• Combinatorial epigenetic perturbations:

  • Systematically inhibit or activate specific writers and erasers

  • Monitor changes in H2B K12 acetylation patterns

  • Identify epistatic relationships between modifications

• Mass spectrometry approaches:

  • Perform immunoprecipitation with Acetyl-H2BFS (K12) Antibody

  • Analyze co-occurring modifications using mass spectrometry

  • Quantify modification stoichiometry on single molecules

• Integrative genomics:

  • Generate ChIP-seq datasets for multiple histone marks

  • Apply computational algorithms to identify modification patterns

  • Develop predictive models of modification dependencies

• Single-molecule imaging:

  • Combine Acetyl-H2BFS (K12) Antibody with antibodies against other marks

  • Use super-resolution microscopy to visualize co-occurrence

  • Track dynamics of modifications in living cells

How can studies of chromatin dynamics utilize Acetyl-H2BFS (K12) Antibody effectively?

To investigate dynamic chromatin processes:

• Time-course experiments:

  • Apply ChIP or Western blotting at defined intervals following stimulation

  • Track acetylation dynamics during cell cycle progression

  • Monitor responses to external signals or stress conditions

• Live-cell imaging approaches:

  • Develop cell-permeable derivatives of the antibody

  • Engineer cells expressing fluorescently-tagged readers of K12 acetylation

  • Correlate acetylation dynamics with chromatin compaction changes

• Nucleosome turnover studies:

  • Combine with CATCH-IT (Covalent Attachment of Tags to Capture Histones and Identify Turnover)

  • Determine relationship between H2B K12 acetylation and nucleosome stability

  • Correlate with replication timing and transcriptional activity

• Writer/eraser enzyme studies:

  • Identify specific HATs and HDACs regulating K12 acetylation

  • Perform enzyme inhibition time-course experiments

  • Measure acetylation dynamics following enzyme perturbation

• Chromatin accessibility correlation:

  • Integrate H2B K12ac ChIP-seq with ATAC-seq or DNase-seq

  • Analyze temporal relationships between acetylation and accessibility

  • Determine causality through targeted perturbation experiments

What considerations are important when designing experiments to study the interplay between H2B K12 acetylation and DNA damage response?

Given the role of histone modifications in DNA repair processes:

• DNA damage induction protocols:

  • Use site-specific systems (e.g., I-SceI, CRISPR-Cas9)

  • Apply different damage types (UV, gamma radiation, chemical agents)

  • Monitor H2B K12 acetylation dynamics during repair

• Spatiotemporal analysis:

  • Perform ChIP-seq at defined time points after damage

  • Use high-resolution microscopy to track acetylation at damage sites

  • Correlate with recruitment of repair factors

• Functional perturbation:

  • Employ histone mutants (K12R to prevent acetylation, K12Q to mimic acetylation)

  • Inhibit specific writers/erasers of K12 acetylation

  • Assess impacts on repair efficiency and pathway choice

• Mechanistic connections:

  • Investigate interactions between K12ac and other damage-associated marks

  • Examine relationships with chromatin remodelers involved in repair

  • Study potential roles in repair pathway selection

• Cell-type specific responses:

  • Compare normal cells versus cancer cells

  • Analyze primary versus transformed cell lines

  • Evaluate tissue-specific dynamics in response to damage

By implementing these advanced research strategies with Acetyl-H2BFS (K12) Antibody, researchers can gain deeper insights into the complex roles of histone acetylation in chromatin biology and disease mechanisms.